These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27989943)

  • 1. Identification of actin beta-like 2 (ACTBL2) as novel, upregulated protein in colorectal cancer.
    Ghazanfar S; Fatima I; Aslam M; Musharraf SG; Sherman NE; Moskaluk C; Fox JW; Akhtar MW; Sadaf S
    J Proteomics; 2017 Jan; 152():33-40. PubMed ID: 27989943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
    Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
    Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics analysis of differential protein expression identifies heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer.
    Mori K; Toiyama Y; Otake K; Fujikawa H; Saigusa S; Hiro J; Kobayashi M; Ohi M; Tanaka K; Inoue Y; Kobayashi Y; Kobayashi I; Mohri Y; Goel A; Kusunoki M
    Int J Cancer; 2017 Mar; 140(6):1425-1435. PubMed ID: 27925182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
    Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
    J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis.
    Roessler M; Rollinger W; Mantovani-Endl L; Hagmann ML; Palme S; Berndt P; Engel AM; Pfeffer M; Karl J; Bodenmüller H; Rüschoff J; Henkel T; Rohr G; Rossol S; Rösch W; Langen H; Zolg W; Tacke M
    Mol Cell Proteomics; 2006 Nov; 5(11):2092-101. PubMed ID: 16893879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Differentially Expressed Proteins in the Serum of Colorectal Cancer Patients Using 2D-DIGE Proteomics Analysis.
    Lim LC; Looi ML; Zakaria SZ; Sagap I; Rose IM; Chin SF; Jamal R
    Pathol Oncol Res; 2016 Jan; 22(1):169-77. PubMed ID: 26463353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer.
    Ma Y; Peng J; Liu W; Zhang P; Huang L; Gao B; Shen T; Zhou Y; Chen H; Chu Z; Zhang M; Qin H
    Mol Cell Proteomics; 2009 Aug; 8(8):1878-90. PubMed ID: 19460759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
    Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
    J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-dimensional differential in-gel electrophoresis for identification of gastric cancer-specific protein markers.
    Wu C; Luo Z; Chen X; Wu C; Yao D; Zhao P; Liu L; Shi B; Zhu L
    Oncol Rep; 2009 Jun; 21(6):1429-37. PubMed ID: 19424620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis.
    Alfonso P; Núñez A; Madoz-Gurpide J; Lombardia L; Sánchez L; Casal JI
    Proteomics; 2005 Jul; 5(10):2602-11. PubMed ID: 15924290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression analysis of leucine-rich PPR-motif-containing protein (LRPPRC), a candidate colorectal cancer biomarker identified by shotgun proteomics using iTRAQ.
    Nishio T; Kurabe N; Goto-Inoue N; Nakamura T; Sugimura H; Setou M; Maekawa M
    Clin Chim Acta; 2017 Aug; 471():276-282. PubMed ID: 28622966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel proteomic strategy reveal combined alpha1 antitrypsin and cathepsin D as biomarkers for colorectal cancer early screening.
    Xie LQ; Zhao C; Cai SJ; Xu Y; Huang LY; Bian JS; Shen CP; Lu HJ; Yang PY
    J Proteome Res; 2010 Sep; 9(9):4701-9. PubMed ID: 20666480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis of advanced colorectal cancer by laser capture microdissection and two-dimensional difference gel electrophoresis.
    Shi H; Hood KA; Hayes MT; Stubbs RS
    J Proteomics; 2011 Dec; 75(2):339-51. PubMed ID: 21843667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Verification of Two Novel Differentially Expressed Proteins from Non-neoplastic Mucosa and Colorectal Carcinoma Via iTRAQ Combined with Liquid Chromatography-Mass Spectrometry.
    Bai Y; Wang J; Gao Z; Dai E
    Pathol Oncol Res; 2020 Apr; 26(2):967-976. PubMed ID: 30927204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.
    de Wit M; Jimenez CR; Carvalho B; Belien JA; Delis-van Diemen PM; Mongera S; Piersma SR; Vikas M; Navani S; Pontén F; Meijer GA; Fijneman RJ
    Gut; 2012 Jun; 61(6):855-64. PubMed ID: 21890811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential proteomic analysis of human colorectal carcinoma cell lines metastasis-associated proteins.
    Zhao L; Liu L; Wang S; Zhang YF; Yu L; Ding YQ
    J Cancer Res Clin Oncol; 2007 Oct; 133(10):771-82. PubMed ID: 17503081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of 5-fluorouracil response proteins in colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry.
    Wong CS; Wong VW; Chan CM; Ma BB; Hui EP; Wong MC; Lam MY; Au TC; Chan WH; Cheuk W; Chan AT
    Oncol Rep; 2008 Jul; 20(1):89-98. PubMed ID: 18575723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gel-Based Proteomics of Clinical Samples Identifies Potential Serological Biomarkers for Early Detection of Colorectal Cancer.
    Thorsen SF; Gromova I; Christensen IJ; Fredriksson S; Andersen CL; Nielsen HJ; Stenvang J; Moreira JMA
    Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31810358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative proteomic analysis identifies proteins associated with the development and progression of colorectal carcinoma.
    Zhao L; Wang H; Sun X; Ding Y
    FEBS J; 2010 Oct; 277(20):4195-204. PubMed ID: 20812987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative proteomic analysis for the insoluble fractions of colorectal cancer patients.
    Yang HY; Kwon J; Park HR; Kwon SO; Park YK; Kim HS; Chung YJ; Chang YJ; Choi HI; Chung KJ; Lee DS; Park BJ; Jeong SH; Lee TH
    J Proteomics; 2012 Jun; 75(12):3639-53. PubMed ID: 22564821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.